Acasti Pharma Inc (ACST)

1.460
-0.060(-3.95%)
  • Volume:
    17,061
  • Bid/Ask:
    1.450/1.470
  • Day's Range:
    1.460 - 1.520
  • Type:Equity
  • Market:Canada
  • ISIN:CA00430K8730
  • CUSIP:00430K873

ACST Overview

Prev. Close
1.52
Day's Range
1.46-1.52
Revenue
251.68K
Open
1.51
52 wk Range
1.33-12.4
EPS
-0.71
Volume
17,061
Market Cap
64.66M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
33,588
P/E Ratio
-
Beta
1.44
1-Year Change
-80.16%
Shares Outstanding
44,288,183
Next Earnings Date
Feb. 17, 2022
What is your sentiment on Acasti Pharma Inc?
or
Market is currently closed. Voting is open during market hours.

Acasti Pharma Inc Company Profile

Employees
32
Market
Canada

Acasti Pharma Inc. is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN). The Company's lead product candidate includes GTX-104, which is a clinical-stage nanoparticle formulation of nimodipine being developed for IV infusion in SAH patients. The Company's other pipeline products include GTX-102, an oral mucosal spray formulation of betamethasone intended to develop neurological symptoms of A-T, including developing clinical assessments of posture and gait disturbance, and kinetic speech and oculomotor functions. GTX-101 is a topical bio-adhesive film-forming spray of bupivacaine for the treatment of PHN.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellNeutralStrong SellStrong Sell
SummaryStrong SellStrong SellSellStrong SellStrong Sell
  • Buy here
    0
    • Waiting patiently before it pops
      0
      • Zom zom zom🚀🚀🚀
        0
        • bought again
          0
          • big disaster
            0
            • going to the moon
              0
              • when 22??
                0
              • when
                0
              • how was that trip?
                0
            • What a disaster!
              0
              • $9 cad stock
                2
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.